Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.

Bodur H, Yurdakul FG, Çay HF, Uçar Ü, Keskin Y, Sargın B, Gürer G, Yurdakul OV, Çalış M, Deveci H, Aydın Y, Hizmetli S, Çevik R, Karahan AY, Sunar İ, Duruöz MT, Ecesoy H, Günendi Z, Toprak M, Şen N, Altıntaş D, Cengiz AK, Çağlayan G, Demir AN, Kaplan H, Ketenci S, Melikoğlu MA, Nayimoğlu M, Nas K, Sarıfakıoğlu AB, Sezer İ.

Rheumatol Int. 2019 Sep 14. doi: 10.1007/s00296-019-04443-0. [Epub ahead of print]

PMID:
31522233
2.

Psoriasis and Guillain-Barré Syndrome: Incidental or Associated?

Sargin B, Gürer G.

Arch Rheumatol. 2017 Apr 11;32(3):273-274. doi: 10.5606/ArchRheumatol.2017.6296. eCollection 2017 Sep. No abstract available.

3.

Coexistence of Late-Onset Systemic Lupus Erythematosus With Focal Segmental Glomerulosclerosis and Lichen Planus: A Case Report.

Sargin B, Gürer G.

Arch Rheumatol. 2017 Feb 11;32(2):162-166. doi: 10.5606/ArchRheumatol.2017.6109. eCollection 2017 Jun.

4.

Rituximab Treatment in a Patient With Primary Biliary Cirrhosis and Rheumatoid Arthritis.

Sargin B, Gürer G.

Arch Rheumatol. 2016 Jul 28;31(4):384-385. doi: 10.5606/ArchRheumatol.2016.5870. eCollection 2016 Dec. No abstract available.

5.

The relationship between C-reactive protein rs3091244 polymorphism and ankylosing spondylitis.

Akbal A, Reşorlu H, Gökmen F, Savaş Y, Zateri Ç, Sargin B, Bozkurt E, Sılan F, Özdemir Ö.

Int J Rheum Dis. 2016 Jan;19(1):43-8. doi: 10.1111/1756-185X.12619. Epub 2015 Oct 20.

PMID:
26480896
6.
7.

SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control.

Reddy PN, Sargin B, Choudhary C, Stein S, Grez M, Müller-Tidow C, Berdel WE, Serve H, Brandts CH; Study Alliance Leukemia (SAL).

Blood. 2012 Aug 23;120(8):1691-702. Epub 2012 Apr 19.

PMID:
22517899
8.

Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.

Pohlen M, Sargin B, Zicholl S, Bisping G, Müller-Tidow C, Berdel WE, Mesters R, Koschmieder S.

Eur J Haematol. 2010 Apr;84(4):362-4. doi: 10.1111/j.1600-0609.2009.01406.x. Epub 2009 Dec 24. No abstract available.

PMID:
20050881
9.

E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.

Bandi SR, Brandts C, Rensinghoff M, Grundler R, Tickenbrock L, Köhler G, Duyster J, Berdel WE, Müller-Tidow C, Serve H, Sargin B; Study Alliance Leukemias.

Blood. 2009 Nov 5;114(19):4197-208. doi: 10.1182/blood-2008-12-190934. Epub 2009 Sep 4.

PMID:
19734451
10.

S100A2 induces metastasis in non-small cell lung cancer.

Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, Hotfilder M, Marra A, Koschmieder S, Dugas M, Berdel WE, Serve H, Müller-Tidow C.

Clin Cancer Res. 2009 Jan 1;15(1):22-9. doi: 10.1158/1078-0432.CCR-08-0953.

11.

Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.

Tickenbrock L, Hehn S, Sargin B, Choudhary C, Bäumer N, Buerger H, Schulte B, Müller O, Berdel WE, Müller-Tidow C, Serve H.

Int J Oncol. 2008 Dec;33(6):1215-21.

PMID:
19020754
12.

Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia.

Tickenbrock L, Hehn S, Sargin B, Evers G, Ng PR, Choudhary C, Berdel WE, Müller-Tidow C, Serve H.

Int J Hematol. 2008 Sep;88(2):174-180. doi: 10.1007/s12185-008-0141-0. Epub 2008 Jul 31.

PMID:
18668305
13.

Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.

Bulk E, Hascher A, Liersch R, Mesters RM, Diederichs S, Sargin B, Gerke V, Hotfilder M, Vormoor J, Berdel WE, Serve H, Müller-Tidow C.

Cancer Res. 2008 Mar 15;68(6):1896-904. doi: 10.1158/0008-5472.CAN-07-2390.

14.

CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.

Koschmieder S, D'Alò F, Radomska H, Schöneich C, Chang JS, Konopleva M, Kobayashi S, Levantini E, Suh N, Di Ruscio A, Voso MT, Watt JC, Santhanam R, Sargin B, Kantarjian H, Andreeff M, Sporn MB, Perrotti D, Berdel WE, Müller-Tidow C, Serve H, Tenen DG.

Blood. 2007 Nov 15;110(10):3695-705. Epub 2007 Aug 1.

15.

Flt3-dependent transformation by inactivating c-Cbl mutations in AML.

Sargin B, Choudhary C, Crosetto N, Schmidt MHH, Grundler R, Rensinghoff M, Thiessen C, Tickenbrock L, Schwäble J, Brandts C, August B, Koschmieder S, Bandi SR, Duyster J, Berdel WE, Müller-Tidow C, Dikic I, Serve H.

Blood. 2007 Aug 1;110(3):1004-12. Epub 2007 Apr 19.

PMID:
17446348
16.

Activation mechanisms of STAT5 by oncogenic Flt3-ITD.

Choudhary C, Brandts C, Schwable J, Tickenbrock L, Sargin B, Ueker A, Böhmer FD, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2007 Jul 1;110(1):370-4. Epub 2007 Mar 13.

PMID:
17356133
17.

Wnt signaling regulates transendothelial migration of monocytes.

Tickenbrock L, Schwäble J, Strey A, Sargin B, Hehn S, Baas M, Choudhary C, Gerke V, Berdel WE, Müller-Tidow C, Serve H.

J Leukoc Biol. 2006 Jun;79(6):1306-13. Epub 2006 Mar 24.

PMID:
16565323
18.

Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation.

Brandts CH, Sargin B, Rode M, Biermann C, Lindtner B, Schwäble J, Buerger H, Müller-Tidow C, Choudhary C, McMahon M, Berdel WE, Serve H.

Cancer Res. 2005 Nov 1;65(21):9643-50.

19.

AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.

Choudhary C, Schwäble J, Brandts C, Tickenbrock L, Sargin B, Kindler T, Fischer T, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2005 Jul 1;106(1):265-73. Epub 2005 Mar 15.

PMID:
15769897
20.

Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.

Tickenbrock L, Schwäble J, Wiedehage M, Steffen B, Sargin B, Choudhary C, Brandts C, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2005 May 1;105(9):3699-706. Epub 2005 Jan 13.

PMID:
15650056
21.

RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

Schwäble J, Choudhary C, Thiede C, Tickenbrock L, Sargin B, Steur C, Rehage M, Rudat A, Brandts C, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2005 Mar 1;105(5):2107-14. Epub 2004 Nov 9.

PMID:
15536149
22.

Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

Müller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Köhler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H.

Mol Cell Biol. 2004 Apr;24(7):2890-904.

23.

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.

Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Böhmer FD, Müller-Tidow C, Berdel WE, Serve H.

Blood. 2003 Apr 15;101(8):3164-73. Epub 2002 Dec 5.

PMID:
12468433

Supplemental Content

Loading ...
Support Center